AstraZeneca Gets in on ADC Therapeutics' Mega $200M Funding Round Post author:Sam Post published:October 22, 2017 Post category:BioPharma ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace You Might Also Like Biotech Startup Autolus Closes $80 Million for Novel Cancer Program September 25, 2017 Former GlaxoSmithKline CEO and R&D Boss Secure New Gigs at Biotech VC Firms September 18, 2017 <b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017
<b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017